日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A potent inhibitor of PAI-1, MDI-2517, mitigates disease severity in a preclinical systemic sclerosis model

PAI-1 的强效抑制剂 MDI-2517 可减轻临床前系统性硬化症模型中的疾病严重程度。

Su, Enming J; Tsou, Pei-Suen; Warnock, Mark; Subbotina, Natalya; Mann, Kris; Vichaikul, Sirapa; Rosek, Alyssa; Leung, Lisa; Xing, Xianying; Xing, Enze; Plazyo, Olesya; Bogle, Rachael; Tsoi, Lam C; Emal, Cory D; Khanna, Dinesh; Varga, John; Sisson, Thomas H; Gudjonsson, Johann E; Lawrence, Daniel A

Acinetobacter Baumannii Secreted Protease CpaA Inhibits Factor XII-Mediated Bradykinin Generation and Neutrophil Activation

鲍曼不动杆菌分泌的蛋白酶CpaA抑制因子XII介导的缓激肽生成和中性粒细胞活化

Blair, Kris M; Bohinc, Dillon J; Bane, Kara L; Warnock, Mark; Abuaita, Basel; Gura, Colby; Grinsztejn, Eduarda; Marshall, Steven H; Wilson, Brigid M; Bonomo, Robert A; Tambralli, Ajay; Knight, Jason S; O'Riordan, Mary X; Lawrence, Daniel A; Stavrou, Evi X; Sandkvist, Maria

PAI-1 interaction with sortilin-related receptor 1 is required for lung fibrosis.

PAI-1 与 sortilin 相关受体 1 的相互作用是肺纤维化所必需的

Sisson Thomas H, Osterholzer John J, Leung Lisa, Basrur Venkatesha, Nesvizhskii Alexey, Subbotina Natalya, Warnock Mark, Torrente Daniel, Virk Ammara Q, Gutor Sergey S, Horowitz Jeffrey C, Migliorini Mary, Strickland Dudley K, Kim Kevin K, Huang Steven K, Lawrence Daniel A

Targeting Plasminogen Activator Inhibitor-1 with a Novel Small Molecule Inhibitor Attenuates Lung Fibrosis.

利用新型小分子抑制剂靶向纤溶酶原激活物抑制剂-1可减轻肺纤维化

Sisson Thomas H, Fortier Sean, Tsoi Lam C, Alonzo Roxann, Subbotina Natalya, Warnock Mark, Mann Kris, Gutor Sergey S, Hartman J Craig, Gudjonsson Johann E, Su Enming J, Emal Cory D, Lawrence Daniel A

Dynamic interplay between sortilin and syndecan-1 contributes to prostate cancer progression

分拣蛋白和 syndecan-1 之间的动态相互作用导致前列腺癌进展

Joanna Lazniewska, Ka Lok Li, Ian R D Johnson, Alexandra Sorvina, Jessica M Logan, Carmela Martini, Courtney Moore, Ben S-Y Ung, Litsa Karageorgos, Shane M Hickey, Sarita Prabhakaran, Jessica K Heatlie, Robert D Brooks, Chelsea Huzzell, Nicholas I Warnock, Mark P Ward, Bashir Mohammed, Prerna Tewari

Imatinib treatment reduces brain injury in a murine model of traumatic brain injury

伊马替尼治疗可减轻小鼠创伤性脑损伤模型中的脑损伤。

Su, Enming J; Fredriksson, Linda; Kanzawa, Mia; Moore, Shannon; Folestad, Erika; Stevenson, Tamara K; Nilsson, Ingrid; Sashindranath, Maithili; Schielke, Gerald P; Warnock, Mark; Ragsdale, Margaret; Mann, Kris; Lawrence, Anna-Lisa E; Medcalf, Robert L; Eriksson, Ulf; Murphy, Geoffrey G; Lawrence, Daniel A

Taming neonatal hypoxic-ischemic brain injury by intranasal delivery of plasminogen activator inhibitor-1.

通过鼻内给药纤溶酶原激活物抑制剂-1治疗新生儿缺氧缺血性脑损伤

Yang Dianer, Sun Yu-Yo, Lin Xiaoyi, Baumann Jessica M, Warnock Mark, Lawrence Daniel A, Kuan Chia-Yi

Novel bis-arylsulfonamides and aryl sulfonimides as inactivators of plasminogen activator inhibitor-1 (PAI-1)

新型双芳基磺酰胺和芳基磺酰亚胺作为纤溶酶原激活物抑制剂-1 (PAI-1) 的灭活剂

El-Ayache, Nadine C; Li, Shih-Hon; Warnock, Mark; Lawrence, Daniel A; Emal, Cory D

Visceral adipose tissue inflammation accelerates atherosclerosis in apolipoprotein E-deficient mice

内脏脂肪组织炎症会加速载脂蛋白E缺陷小鼠的动脉粥样硬化。

Ohman, Miina K; Shen, Yuechun; Obimba, Chinyere I; Wright, Andrew P; Warnock, Mark; Lawrence, Daniel A; Eitzman, Daniel T